EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Etiological Spectrum and Maternal Peripartum Hematologic Outcomes of Thrombocytopenia in Pregnancy: A Retrospective Cohort Study

Bilge Erbey iD, Cemal Reşat Atalay, Sait Erbey iD

Medicina · 16.04.2026 · 62 (4) · 771

DOI: 10.3390/medicina62040771 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Medicina, online erschienen am 16.04.2026. Verfasst von Bilge Erbey und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Ankara Numune Training and Research Hospital, University of Health Sciences, Ankara 06010, Turkey. Hauptthemen laut MEDLINE: Thrombocytopenia, Pregnancy Complications, Hematologic. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Thrombocytopenia complicates 6.6–11.6% of pregnancies. While gestational thrombocytopenia (GT) is usually benign, etiologies such as immune thrombocytopenia (ITP), preeclampsia, and HELLP syndrome require individualized management. This study aimed to characterize the etiological spectrum, maternal peripartum hematologic outcomes, blood product utilization, and mode of delivery in a tertiary-center cohort of thrombocytopenic pregnancies and to assess whether platelet count should influence delivery mode decisions. Materials and Methods: This retrospective cohort study included 137 thrombocytopenic pregnant women at a tertiary center (2010–2019), categorized by etiology and severity. Peripartum hemoglobin, hematocrit, and platelet counts were compared between delivery groups. Blood product utilization was recorded and analyzed using t-test, ANOVA, chi-square, Fisher’s exact, and Fisher–Freeman–Halton tests; binary logistic regression was used for multivariable analysis.

Results

GT (43.1%) and ITP (32.1%) were the most prevalent diagnoses; cesarean delivery rate was 52.6%. Postpartum Hb was higher in the vaginal delivery group (10.24 ± 1.28 vs. 9.80 ± 1.26 g/dL; p = 0.003), while platelet counts were paradoxically lower (p = 0.039). Platelet transfusion rates did not differ significantly between delivery modes (23.1% vs. 27.8%; p = 0.621). Severe thrombocytopenia required platelet transfusion in 92.6% of cases versus 11.6% (moderate) and 0% (mild) (p < 0.001). RBC transfusion was highest in gestational hypertensive disease (41.2%) versus GT (5.1%) and ITP (2.3%) (p < 0.001). General anesthesia was used in 75% of cesarean cases.

Conclusions

Delivery mode in thrombocytopenic pregnancies should be guided by obstetric indications, not platelet count alone. Although postpartum platelet counts declined more steeply after vaginal delivery, this did not increase transfusion requirements. Gestational hypertensive disorders carried the greatest hemorrhagic burden, highlighting the need for etiology-specific multidisciplinary planning. The high general anesthesia rate warrants prospective institutional audit of anesthetic decision-making protocols to determine adherence to current neuraxial anesthesia thresholds. This study is limited to maternal peripartum hematologic outcomes; neonatal outcomes were not captured and should be addressed in future prospective research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaPregnancy Complications, HematologicHumansFemalePregnancyRetrospective StudiesAdultCohort StudiesPeripartum PeriodPlatelet CountDelivery, ObstetricLogistic ModelsPregnancy Outcome

Stichwörter der Autor:innen

HELLP syndromegestational thrombocytopeniaimmune thrombocytopeniamode of deliveryperipartum hemorrhageplatelet transfusionpregnancythrombocytopenia

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Ankara Numune Training and Research Hospital, University of Health Sciences, Ankara 06010, Turkey.
  • Department of Obstetrics and Gynecology, Ankara Etlik Şehir Hastanesi, Ankara 06170, Turkey.

ORCID-Profile: Bilge Erbey, Sait Erbey

Zitieren

APA

Erbey, B., Atalay, C. R., & Erbey, S. (2026). Etiological Spectrum and Maternal Peripartum Hematologic Outcomes of Thrombocytopenia in Pregnancy: A Retrospective Cohort Study. Medicina, 62(4), 771. https://doi.org/10.3390/medicina62040771

Vancouver

Erbey B, Atalay CR, Erbey S. Etiological Spectrum and Maternal Peripartum Hematologic Outcomes of Thrombocytopenia in Pregnancy: A Retrospective Cohort Study. Medicina. 2026;62(4):771. doi:10.3390/medicina62040771

BibTeX
@article{Erbey2026,
  author = {Erbey, Bilge and Atalay, Cemal Reşat and Erbey, Sait},
  title = {Etiological Spectrum and Maternal Peripartum Hematologic Outcomes of Thrombocytopenia in Pregnancy: A Retrospective Cohort Study},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {4},
  pages = {771},
  doi = {10.3390/medicina62040771}
}
Kostenlos starten →